Position
Fidelity in Maxcyte, Inc.
Back to the book · All holders of MXCT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $95.1K$0.70 → $1.23
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 144.4K | $223.8K | — | — | — | 0.0% |
| Q1 2026 | 190.1K | $133.6K | $0.70 | −$122.4K | $32.1K | 0.0% |
| Q2 2026 | 180.3K | $221.8K | $1.23 | $95.1K | −$6.88K | 0.0% |